Feedback / Questions
Rhapsido (remibrutinib) - Novartis
Xolair (omalizumab) - Roche, Novartis
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42705809
Delphine Gobert; Jonathan A Bernstein; Sanchita Paranthaman; Tukisa Smith; Yossi Rosman
Sep 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next